Anti-diabetic and anti-oxidative activity of fixed oil extracted from Ocimum sanctum L. leaves in diabetic rats

Experimental and Therapeutic Medicine

Volumn 11, Issue 3, 2016, Pages 832-840

  Suanarunsawat, Thamolwan ^a   Anantasomboon, Gun ^b   Piewbang, Chutchai ^c  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b RANGSIT UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; CREATININE; FATTY ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; LACTATE DEHYDROGENASE; LINOLENIC ACID; LIPID PEROXIDE; OCIMUM SANCTUM EXTRACT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDATIVE ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 84955578948     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.2991     Document Type: Article

References (47)

1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1): 62-69, 2010.
2. Rochette L, Zeller M, Cottin Y and Vergely C: Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta 1840: 2709-2729, 2014.
3. Wild S, Roglic G, Green A, Sicree R and King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
4. World Health Organization: The top 10 causes of death. Fact sheet No. 310. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed May, 2014.
5. Emilien G, Maloteaux JM and Ponchon M: Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment. Pharmacol Ther 81: 37-51, 1999.
6. Suanarunsawat T, Ayutthaya WD, Songsak T, Thirawarapan S and Poungshompoo S: Lipid-lowering and antioxidative activities of aqueous extracts of Ocimum sanctum L. leaves in rats fed with a high-cholesterol diet. Oxid Med Cell Longev 2011: 962025, 2011.
7. Taleb-Senouci D, Ghomari H, Krouf D, Bouderbala S, Prost J, Lacaille-Dubois MA and Bouchenak M: Antioxidant effect of Ajuga iva aqueous extract in streptozotocin-induced diabetic rats. Phytomedicine 16: 623-631, 2009.
8. Sarkhail P, Rahmanipour S, Fadyevatan S, Mohammadirad A, Dehghan G, Amin G, Shafiee A and Abdollahi M: Antidiabetic effect of Phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 56: 261-266, 2007.
9. Pattanayak P, Behera P, Das D and Panda SK: Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev 4: 95-105, 2010.
10. Cohen MM: Tulsi-Ocimum sanctum: A herb for all reasons. J Ayurveda Integr Med 5: 251-259, 2014.
11. Chandrasekaran CV, Srikanth HS, Anand MS, Allan JJ, Viji MM and Amit A: Evaluation of the mutagenic potential and acute oral toxicity of standardized extract of Ocimum sanctum (OciBest™). Hum Exp Toxicol 32: 992-1004, 2013.
12. Gautam MK and Goel RK: Toxicological study of Ocimum sanctum linn leaves: Hematological, biochemical and histopathological studies. J Toxicol 2014: 135654, 2014.
13. Mahajan N, Rawal S, Verma M, Poddar M and Alok S: A phytopharmacological overview on Ocimum species with special emphasis on Ocimum sanctum. Biomed Prevent Nutr 3: 185-192, 2013.
14. Suanarunsawat T and Songsak T: Anti-hyperglycemic and anti-hyperlipidemic effect of dietary supplement of white Ocimum sanctum L. before and after STZ-induced diabetes mellitus. Inter J Diabetes Metab 13: 18-23, 2005.
15. Narendhirakannan RT, Subramanian S and Kandaswamy M: Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats. Clin Exp Pharmacol Physiol 33: 1150-1157, 2006.
16. Suanarunsawat T, Ayutthaya WD, Thirawarapan S and Poungshompoo S: Anti-oxidative, anti-hyperglycemic and lipid-lowering effects of aqueous extracts of Ocimum sanctum L. leaves in diabetic rats. Food Nutr Sci 5: 801-811, 2014.
17. Reddy SS, Karuna R, Baskar R and Saralakumari D: Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose-fed rats. Horm Metab Res 40: 44-49, 2008.
18. Shetty S, Udupa S and Udupa L: Evaluation of antioxidant and wound healing effects of alcoholic and aqueous extract of Ocimum sanctum linn in rats. Evid Based Complement Alternat Med 5: 95-101, 2008.
19. Bhattacharyya P and Bishayee A: Ocimum sanctum Linn. (Tulsi): An ethnomedicinal plant for the prevention and treatment of cancer. Anticancer Drugs 24: 659-666, 2013.
20. Sharmila Banu G, Kumar G and Murugesan AG: Effects of leaves extract of Ocimum sanctum L. on arsenic-induced toxicity in Wistar albino rats. Food Chem Toxicol 47: 490-495, 2009.
21. Ramesh B and Satakopan VN: Antioxidant activities of hydroalcoholic extract of Ocimum sanctum against cadmium induced toxicity in rats. Indian J Clin Biochem 25: 307-310, 2010.
22. Hussain EH, Jamil K and Rao M: Hypoglycaemic, hypolipidemic and antioxidant properties of tulsi (Ocimum sanctum linn) on streptozotocin induced diabetes in rats. Indian J Clin Biochem 16: 190-194, 2001.
23. Suanarunsawat T, Devakul Na Ayutthaya W, Songsak T, Thirawarapan S and Poungshompo S: Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a high cholesterol diet. J Clin Biochem Nutr 46: 52-59, 2010.
24. Suanarunsawat T, Boonnak T, Na Ayutthaya WD and Thirawarapan S: Anti-hyperlipidemic and cardioprotective effects of Ocimum sanctum L. fixed oil in rats fed a high fat diet. J Basic Clin Physiol Pharmacol 21: 387-400, 2010.
25. Su J, Zhang P, Zhang JJ, Qi XM, Wu YG and Shen JJ: Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats. Phytomedicine 17: 254-260, 2010.
26. Li CJ, Lv L, Li H and Yu DM: Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol 11: 73, 2012.
27. Mercer BN, Morais S, Cubbon RM and Kearney MT: Diabetes mellitus and the heart. Int J Clin Prac 66: 640-647, 2012.
28. AOAC International: Method 948.22. In: Official Methods of Analysis of AOAC International. 16th edition. Association of Analytical Communities, Washington, DC, 1995.
29. International Organization for Standardization (ISO): Animal and vegetable fats and oils: Preparation of methyl esters of fatty acids (Method ISO 5509). ISO, Geneva, pp 1-6, 1978.
30. Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
31. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
32. Tapple AL: Glutathione peroxidase and hydroperoxidase methods. In: Methods in Enzymology. Vol 2. Sidney F and Lester P (eds). Academic Press, New York, NY, pp 506-513, 1978.
33. Luck H: Catalase. In: Method for Enzymatic Analysis. Vol 3. Bergmeyer HU (ed). Academic Press, New York and London, pp 885-894, 1965.
34. Winterbourn CC, Hawkins RE, Brian M and Carrell RW: The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85: 337-341, 1975.
35. Hewitson TD, Wigg B and Becker GJ: Tissue preparation for histology: Fixation, embedding, and antigen retrieval for light microscopy. Methods Mol Biol 611: 3-18, 2010.
36. Reichard P and Pihl M: Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 43: 313-317, 1994.
37. Elsner M, Guldbakke B, Tiedge M, Munday R and Lenzen S: Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533, 2000.
38. Moran BM, Abdel-Wahab YH, Flatt PR and McKillop AM: Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells. Diabetes Obes Metab 16: 1128-1139, 2014.
39. Khamaisi M, Rudich A, Beeri I, Pessler D, Friger M, Gavrilov V, Tritschler H and Bashan N: Metabolic effects of gamma-linolenic acid-alpha lipoic acid conjugate in streptozotocin diabetic rats. Antioxid Redox Signal 1: 523-535, 1999.
40. Halliwell B and Chirico S: Lipid peroxidation: Its mechanism, measurement and significance. Am J Clin Nutr 57 (5 Suppl): 715S-725S, 1993.
41. Rochette L, Zeller M, Cottin Y and Vergely C: Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta 1840: 2709-2729, 2014.
42. King GL and Loeken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122: 333-338, 2004.
43. Kumar S, Prasad S and Sitasawad SL: Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats. PLoS One 8: e67009, 2013.
44. Zobali F, Avci A, Canbolat O and Karasu C: Effects of vitamin A and insulin on the anti-oxidative state of diabetic rat heart: A comparison study with combination treatment. Cell Biochem Funct 20: 75-80, 2002.
45. Suanarunsawat T, Ayutthaya WD, Songsak T and Rattanamahaphoom J: Anti-lipidemic actions of essential oil extracted from Ocimum sanctum L. leaves in rats fed with high cholesterol diet. J Appl Biomed 7: 45-53, 2009.
46. Barcelli UO, Weiss M, Beach D, Motz A and Thompson B: High linoleic acid diets ameliorate diabetic nephropathy in rats. Am J Kidney Dis 16: 244-251, 1990.
47. Jiang M, Zheng J, Yu W, Lv G, Xu Q, Zhou Y and Zhai C: Protective effect of ALA on high glucose induced cellular injury of LLC-PK1 cell. Wei Sheng Yan Jiu 41: 191-194, 2012 (In Chinese).